Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Ju-Yeun, Kim, Yul Hee, Yi, Nam-Joon, Kim, Hyang Sook, Lee, Hye Suk, Lee, Byung Koo, Kim, Hyeyoung, Choi, Young Rok, Hong, Geun, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099335/
https://ncbi.nlm.nih.gov/pubmed/25032186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.2.192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados